Cytoskeletal protection: Acting on notch to prevent neuronal dysfunction

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 93-95

  Bonini, Sara Anna ^a   Ferrari Toninelli, Giulia ^a   Maccarinelli, Giuseppina ^a   Bettinsoli, Paola ^a   Montinaro, Mery ^a   Memo, Maurizio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Alzheimer's disease; Cytoskeletal protection; Dysfunctional neurons; Neurite remodeling; Neuroplasticity; Notch pathway

Indexed keywords

NOTCH RECEPTOR; GAMMA SECRETASE INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; SPASTIN; TAU PROTEIN;

ARTICLE; BRAIN REGION; CELL FATE; CELL PROTECTION; CYTOSKELETON; DEGENERATIVE DISEASE; HUMAN; NERVE CELL LESION; NERVE CELL PLASTICITY; NEURITE; NONHUMAN; PRIORITY JOURNAL; ALZHEIMER DISEASE; BRAIN CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CONFERENCE PAPER; GENE EXPRESSION PROFILING; IN VITRO STUDY; MICROTUBULE; NERVE CELL DEGENERATION; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

BRAIN; CYTOSKELETON; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84896727929     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000354230     Document Type: Article

References (18)

1. Cairns NJ, Lee VM, Trojanowski JQ: The cytoskeleton in neurodegenerative diseases. J Pathol 2004; 204: 438-449.
2. Trojanowski JQ, Smith AB, Huryn D, Lee VM: Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments. Expert Opin Pharmacother 2005; 6: 683-686.
3. Roy S, Zhang B, Lee VM, Trojanowski JQ: Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 2005; 109: 5-13.
4. Michaelis ML, Seyb KI, Ansar S: Cytoskeletal integrity as a drug target. Curr Alzheimer Res 2005; 2: 227-229.
5. Nelson R: Microtubule-stabilising drugs may be therapeutic in AD. Lancet Neurol 2005; 4: 83-84.
6. Louvi A, Artavanis-Tsakonas S: Notch signalling in vertebrate neural development. Nat Rev Neurosci 2006; 7: 93-102.
7. Nikonenko I, Jourdain P, Muller D: Presynaptic remodeling contributes to activity-dependent synaptogenesis. J Neurosci 2003; 23: 8498-8505.
8. Ferrari-Toninelli G, Bonini SA, Uberti D, Napolitano F, Stante M, Santoro F, Monopoli G, Zambrano N, Russo T, Memo M: Notch activation induces neurite remodeling and functional modifications in SH-SY5Y neuronal cells. Dev Neurobiol 2009; 69: 378-391.
9. Trotta N, Orso G, Rossetto MG, Daga A, Broadie K: The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 2004; 14: 1135-1147.
10. Eckert T, Le DT, Link S, Friedmann L, Woehlke G: Spastin's microtubule-binding properties and comparison to katanin. PLoS One 2012; 7:e50161.
11. Evans KJ, Gomes ER, Reisenweber SM, Gundersen GG, Lauring BP: Linking axonal degeneration to microtubule remodeling by spastin-mediated microtubule severing. J Cell Biol 2005; 168: 599-606.
12. Eckert T, Link S, Le DT, Sobczak JP, Gieseke A, Richter K, Woehlke G: Subunit interactions and cooperativity in the microtubulesevering AAA ATPase spastin. J Biol Chem 2012; 287: 26278-26290.
13. Ferrari-Toninelli G, Bonini SA, Bettinsoli P, Uberti D, Memo M: Microtubule stabilizing effect of notch activation in primary cortical neurons. Neuroscience 2008; 154: 946-952.
14. Verhey KJ, Gaertig J: The tubulin code. Cell Cycle 2007; 6: 2152-2160.
15. Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189: 167-169.
16. Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E: Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. J Neurosci 2002; 22: 9298-9304.
17. Bonini SA, Ferrari-Toninelli G, Uberti D, Montinaro M, Buizza L, Lanni C, Grilli M, Memo M: Nuclear factor κB-dependent neurite remodeling is mediated by Notch pathway. J Neurosci 2011; 31: 11697-11705.
18. Lu ZY, Yu SP, Wei JF, Wei L: Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience 2006; 139: 965-978.